At NeuDirection, we are dedicated to developing a robust and diverse pipeline of innovative neurological therapies. Our pipeline encompasses a range of promising small molecules and neuropeptide-based drug candidates, each targeting specific G protein-coupled receptors (GPCRs) in the brain. By exploring novel mechanisms and pathways, we aim to address significant unmet medical needs in the treatment of neurological disorders.